1. Introduction {#s0005}
===============

Insomnia is common in the general population, but even more prevalent among cancer patients. About two thirds of all the women who have been treated for breast cancer (BRC) experience insomnia symptoms. About one third of them fulfill the criteria for an insomnia disorder ([@bb0140]). This is defined by (a) dissatisfaction with sleep quantity or quality (sleep onset latency or wake after sleep onset or early morning awakening ≥ 30 min), (b) for 3 or more nights a week, (c) for at least 3 months, (d) causing clinically significant impairment in day-time functioning, (e) which cannot be explained by other sleep disorders or by drugs ([@bb0005]).

About three-quarter of all people who visit a physician for insomnia receive medication, mostly benzodiazepines ([@bb0015], [@bb0060]). Although medication is effective in the short term, it has negative side effects and significant risks ([@bb0025]). The preferred treatment for insomnia is cognitive behavioral therapy (CBT; [@bb0035]). CBT is as effective as medication in the short term and more effective in the long term ([@bb0020], [@bb0045], [@bb0095], [@bb0105], [@bb0115]). However, the availability of CBT is limited because of a lack of qualified therapists. Moreover, accessibility is hampered by geographic distances, and personal limitations on travel and costs. For these reasons Internet-CBT (I-CBT) has been developed.

A number of different studies have demonstrated the effectiveness of internet based treatment for insomnia among otherwise healthy patients ([@bb0175], [@bb0055], [@bb2017], [@bb0160]). The Dutch CBT intervention I-Sleep, which is used in the current study, is an example of this ([@bb0180]).

Many BRC patients don\'t seek help for their insomnia because they often think that insomnia is a normal and temporary consequence of cancer treatment ([@bb0020]). Nevertheless, the body of evidence that CBT can effectively reduce insomnia in BRC patients is growing ([@bb0050], [@bb0130], [@bb0045]). Furthermore, the first studies on self-administered CBT for insomnia in cancer patients (video- or web-based) also showed promising results ([@bb0145], [@bb0125], [@bb0150]). The question remains whether or not it is feasible to implement an online insomnia intervention for BRC patients in routine care: do they want to use it and do they complete the program? Next, it is unknown if the effects which are established in RCTs are similar to those obtained in routine care. Therefore, the aims of the present study on our adapted guided I-Sleep intervention are:1)How feasible is a guided web-based intervention in routine care: is there a need for this type of program (do BRC patients want to participate), do patients adhere to it, and do they feel that the intervention is worthwhile?2)Is the guided web-based intervention effective? Do BRC patients experience less symptoms after the guided I-CBT in comparison to pre-treatment levels and how do these improvements in terms of effect sizes compare to those obtained in previous RCTs?3)Which BRC patients benefit the most from the guided I-CBT? What demographic, clinical and treatment characteristics are associated with treatment outcomes?

2. Methods/design {#s0010}
=================

2.1. Study design {#s0015}
-----------------

An open mixed methods design was used with web-based pre- and post-treatment questionnaires and semi-structured telephone interviews. The Medical Ethics Committee confirmed that the "Medical Research Involving Human Subjects Act" (WMO) does not apply to the study (registration number 2013.254). The study protocol is also approved by the faculty Ethical Committee and the Scientific Committees of the participating hospitals. All participants provided web-based informed consent, and therewith approved the study procedures and data storage.

2.2. Recruitment {#s0020}
----------------

We collaborated with three hospital-based BRC care units in and around the city of Amsterdam. Specialized nurses directed possibly eligible patients to the Internet site ([www.slaapproblemen-na-borstkanker.nl](http://www.slaapproblemen-na-borstkanker.nl){#ir0005}). On this public website, the study goals and procedures were explained and participants could express their interest in the treatment. Recruitment of participants was also done by advertising on BRC social media sites.

2.3. Inclusion criteria {#s0025}
-----------------------

BRC patients were eligible to participate if they met the following criteria: 1) self-reported insomnia, 2) surgery, chemotherapy and/or radiation treatment for BRC finished three months to five years before inclusion, 3) 18 years or older, 4) sufficient mastery of Dutch language, and 5) access to the internet.

2.4. Guided I-CBT intervention {#s0030}
------------------------------

The I-Sleep intervention comprises six sessions. Each session contains information, a daily sleep diary, exercises, and examples of other BRC patients going through insomnia CBT. Each session covers a different theme: 1) psycho-education on sleep and insomnia, 2) sleep hygiene and behaviors that can hinder or promote sleep, 3) sleep restriction and stimulus control -- starting a new sleep rhythm with fixed (restricted) times for going to bed at night and getting out of bed in the morning, 4) relaxation techniques, 5) dysfunctional thoughts about sleep and 6relapse prevention.

The I-Sleep intervention was adapted for BRC patients based on in-depth interviews with five BRC patients with insomnia, and the available literature on specific characteristics of insomnia related to BRC. Information on postoperative pain, early menopause and hot flushes was added to the psycho-education in the first lesson. Furthermore, three examples of BRC patients with insomnia, representing different situations in terms of age, cancer treatment, and types of sleep difficulties were described and added. The five interviewed patients evaluated and approved the adapted intervention.

After completing the pre-treatment questionnaire and providing informed consent, a coach was assigned to a participant. The coaches were trained psychologists and mental health nurses. They provided weekly online feedback on the assignments in order to provide more explanation if needed and to encourage participants to adhere to the assignments.

2.5. Procedures {#s0035}
---------------

The online pre-treatment questionnaire was sent before the start of the web-based intervention. The post-treatment questionnaire was sent 9 weeks later. A representative subsample of participants was chosen for the semi-structured interviews, selected using the following criteria: younger and older age, (dis)satisfaction with treatment, level of adherence to the treatment, and severity of insomnia symptoms at the start of the treatment. Interviews were conducted until saturation was reached, hence when no new topics were brought up by the patients.

2.6. Within group effects {#s0040}
-------------------------

The primary outcome measure was insomnia severity. Secondary outcome measures were fatigue, daily functioning and symptoms of anxiety and depression.

Insomnia severity was measured with the Insomnia Severity Index (ISI): A 7-item questionnaire with a total score ranging from 0 to 28 ([@bb0100]) and can be divided into: 0--7 = no clinically significant insomnia, 8--14 = sub threshold insomnia, 15--21 = clinical insomnia (moderate severity) and 22--28 = clinical insomnia (severe). The ISI is validated for web delivery ([@bb0185]) and cancer patients ([@bb0135]).

Fatigue was measured with the Fatigue Severity Scale (FSS): A 9-item questionnaire with a total scoring ranging from 9 to 63 ([@bb0065]). Higher scores indicate greater fatigue.

Daily functioning was measured with the Work and Social Adjustment Scale (WSAS): A 4-item questionnaire rated on an 8-point Likert scale (0 = not at all impaired, 8 = very severely impaired). Each item measures a domain of functioning: household, work, friendship and social functioning ([@bb0090]).

Symptoms of anxiety and depression were measured with the Hospital Anxiety and Depression scales (HADS): A 14-item questionnaire ([@bb0195]) with two 7-item subscales: depression (HADS-D) and anxiety (HADS-A), both with a total score range of 0--21. Scores 0--7 excludes a depression or anxiety disorder, scores 8--10 indicate a possible depression or anxiety disorder, scores 11--21 indicate a probable depression or anxiety disorder.

Demographic characteristics in the questionnaire included age, nationality, marital status, educational level and work status. Clinical characteristics included sick leave from work in the previous month, sleep medication use and BRC treatment received (surgery, radiotherapy, chemotherapy, and hormonal therapy).

2.7. Feasibility {#s0045}
----------------

To measure feasibility, we examined the number of lessons finished by the patients. We also evaluated treatment satisfaction with 14 items developed by the research group. Each item was rated on a 3-point Likert scale (0 = fully agree, 1 = neutral, 2 = fully disagree.

The semi-structured interviews aimed at discussing the following topics: motivation for treatment, preferences for web-based or face-to-face treatment, experiences with adaptations made for breast cancer, experiences with coaching, and suggestions for improvement. The interview was conducted by a master student in psychology and took approximately 45 min.

2.8. Data analysis {#s0050}
------------------

First, we described the characteristics of the study population with regard to demographic factors, the history of cancer, insomnia severity, and level of functioning. We investigated potential selective drop-out by comparing the completers of the intervention, with the participants that did not complete the intervention. To test the effect of the intervention we calculated Cohen\'s *d* by dividing the difference in pre- and post-test scores of participants by the pooled standard deviation for each outcome measure ([@bb0030]). A Cohen\'s *d* of 0.00--0.32 is considered as small, 0.33--0.55 as medium, and \> 0.56 as large ([@bb0080], [@bb0085]). We performed intention to treat analyses on our primary outcome measure. Missing post-test scores were imputed using a multiple imputation procedure. For the imputation procedure we included all baseline clinical variables (ISI, FSS, Hads anxiety, Hads depression, WSAS functioning) as well as age, education and number of days between randomisation and start intervention.

Satisfaction with the intervention was assessed with the 14 statements (% agreed). The semi-structured interviews were transcripted and the information was categorised within the themes. For every theme we summarized the main findings.

Finally, in order to identify characteristics of BRC patients who might benefit most from the intervention we performed univariate and multivariate regression analyses on the insomnia improvement scores. We included the following independent variables in the model: demographic characteristic, characteristics on illness history, severity of insomnia, severity of anxiety and depression, and level of functioning.

3. Results {#s0055}
==========

3.1. Baseline characteristics {#s0060}
-----------------------------

The mean age of the 171 women who accessed to the guided internet intervention was 49 years (range 21 to 76, median 50). Most of them were living with their partner or were married (79%). Most women had a paid job (79%), but almost half of those were on sick leave. Most of the women had been treated for BRC with chemotherapy (77.8%) and with hormonal therapy (76%). The mean time between surgery and admission to the intervention was 2.3 years. 51 patients suffered from subthreshold insomnia (ISI score 8--14), 104 patients from clinical insomnia with moderate severity (ISI score 15--21) while the remaining 16 patients suffered from severe clinical insomnia (ISI score \> 21). Most of the women were self-referred to the intervention by information on the internet (66.5%), and 33.5% of the women were referred by routine care procedures. We additionally examined the differences between routine care recruitment and internet recruitment, and found that higher educated women were referred significantly more by medical staff (64.9% vs 46.9%, *p* = 0.03).

We compared the baseline scores of the 100 women who completed the intervention with the 71 women who did not complete the intervention. Non-completers suffered significantly more often from daytime fatigue (*p* \< 0.01), and were more often on sick leave (*p* \< 0.02) ([Table 1](#t0005){ref-type="table"}).Table 1Demographic and baseline characteristics of 171 women who applied to the internet course.Table 1Total\
*N* = 171;\
100%Treatment completed\
*N* = 100 (58.5%)Treatment not completed\
*N* = 71 (42.5%)pDemographic characteristics% Women100%100%100%NAAge mean (SD)49.4 (8.7)50.1 (9.0)48.3 (8.0)0.17% Born in the Netherlands[a](#tf0005){ref-type="table-fn"}84.2%85.0%83.1%0.74% Higher education53.2%59.0%45.1%0.07% Living together78.9%79.0%78.9%0.98% In a paid job78.9%80.0%77.5%0.69% On sick leave47.4%38.8%60.0%0.02  Type of treatment% Complete breast amputation60.8%64.0%56.3%0.31Years between operation and admission to intervention, mean (SD)2.3 (2.1)2.4 (2.2)2.2 (2.0)0.62% Radiotherapy65.5%66.0%64.8%0.87% Chemotherapy77.8%77.0%78.9%0.77% Hormonal therapy76.0%76.0%76.1%0.99% With lymphe oedemia46.8%41.0%54.9%0.07  Sleep characteristicsInsomnia severity index, mean (SD)16.5 (3.6)16.1 (3.4)17.0 (3.9)0.11Fatigue Severity Scale, mean (SD)39.3 (11.1)37.3 (11.1)42.2 (10.6)\< 0.01% With sleep medication45.0%48.0%40.8%0.35% Insomnia before breast cancer38.0%41.0%33.8%0.34% Sleep medication in history25.7%29.0%21.1%0.25% Other sleep treatment in history7.6%8.0%7.0%0.82  Psychological symptoms and functioningHADS-anxiety7.6 (3.7)7.6 (3.7)7.6 (3.8)0.95HADS-depression5.5 (3.7)5.2 (3.5)5.9 (4.0)0.20WSAS functioning (total)16.2 (9.7)15.4 (9.6)17.3 (9.7)0.20WSAS household3.9 (2.8)3.5 (2.6)4.5 (2.9)0.12WSAS work4.5 (3.1)4.4 (3.1)4.6 (3.2)0.63WSAS friendship3.8 (2.8)3.7 (2.7)4.0 (2.8)0.46WSAS social functioning4.0 (2.7)3.9 (2.7)4.2 (2.8)0.48% Medical referral33.5%33.0%34.5%0.86[^1]

3.2. Feasibility: response and adherence {#s0065}
----------------------------------------

During the inclusion period of 9 months 215 patients subscribed, of which 179 (83%) returned the pre-treatment questionnaire ([Fig. 1](#f0005){ref-type="fig"}). Five of those were excluded because they did not meet the inclusion criteria, and 3 did not provide informed consent, leaving 171 included women. This exceeded our expectations which implied that we had to train more therapists than we had planned beforehand.Fig. 1Flow diagram of participants\' progress though the study phases: pre- and post-treatment measurement, and intervention adherence.Fig. 1

Of the 171 women registered to the intervention, 31 (18%) never started. Another 19 (11%) completed only 1 or 2 lessons, 21 (12%) carried out a substantial part of the intervention (3, 4 or 5 lessons) while the remaining 100 (59%) completed the whole course of 6 lessons. Of the 171 women, 122 (71%) returned the post-treatment questionnaire. Finally, 96 women (56%) completed the intervention as well as the pre- and post-measurements.

3.3. Feasibility: experiences of participants {#s0070}
---------------------------------------------

On average, the 122 patients who returned the post-test questionnaire were satisfied with the intervention (value of 7.5 on a scale from 1 to 10). Most of the women (87%) liked the fact that they could work independently on the exercises, and almost all (94%) appreciated the support of the coaches ([Table 2](#t0010){ref-type="table"}). Coaches received a satisfaction score of 7.8 (scale 1--10). The majority (85%) appreciated the information provided in the intervention, although a substantial part (41%) of the women indicted that they had seen some of this information before. Most of the women appreciated the exercises (77%).Table 2Opinions on the internet intervention of 122 participants.Table 2Statement(Fully) agree%Neutral %(Fully) disagree %The intervention contained much new information59%31%10%I appreciated the information on the internet site85%13%2%I found the exercises useful77%18%5%I valued the fact that feedback was provided94%4%2%The feedback of the coach was useful83%14%3%The feedback was motivating75%18%7%The internet site was clearly structured84%15%2%I was easy to find my way on the internet site78%17%5%The site was well readable (font, color, etc)94%6%--The design of the site was nice85%15%--I liked to work independently on my sleep problems87%7%6%The exercises were meaningful74%17%9%The intervention has given me new insights into my sleep problems72%20%9%The intervention taught me to cope with my sleep problems72%20%8%

During the 19 qualitative interviews the following advantages of the web-based intervention were mentioned by the patients: that the intervention was especially designed for BRC patients (the recognition of not being the only one with this problem), that they could carry out the treatment in their own time and place (especially since they already had spent a lot of travel time for their cancer treatment) and that coaching was provided. The feedback was perceived as highly personalized and the women felt well understood. Also the coaching had an important role in encouraging and reminding the women in completing their homework. According to the women, the intervention could be improved by providing more in-depth information on the specific relation between BRC and insomnia, on coping with hot flushes and shoulder pain.

3.4. Within-group effects {#s0075}
-------------------------

We analysed the scores of the 171 women who were admitted to the intervention ([Table 3](#t0015){ref-type="table"}).Table 3Improvements between baseline and post-test (*n* = 171; intention to treat analysis).Table 3Mean scores (SD)BeforeAfterEffect size (95% confidence interval)[a](#tf0010){ref-type="table-fn"}pInsomnia severity index16.5 (3.6)9.2 (4.9)1.33 (1.13/1.54)\< 0.01Fatigue severity scale39.3 (11.1)35.9 (13.2)0.24 (0.08/0.39)\< 0.01HADS-anxiety7.6 (3.7)6.0 (3.7)0.44 (0.28/0.60)\< 0.01HADS-depression5.5 (3.7)4.3 (3.4)0.37 (0.22/0.53)\< 0.01WSAS - functioning16.2 (9.7)12.6 (10.1)0.30 (0.14/0.45)\< 0.01[^2]

The mean Insomnia Severity Index (ISI) score improved significantly from 16 at pre-treatment to 8 at post-treatment, which corresponds to a large effect size of 1.33 (*p* \< 0.01). This means that, on average, there was a shift from moderately severe clinical insomnia (score 15--21) to subthreshold insomnia (score 8--14). Daytime fatigue also improved significantly with a small effect size of 0.24 (*p* \< 0.01). Daily functioning improved significantly as well: women were more capable of functioning (Cohen\'s *d* = 0.30; *p* \< 0.01; [Table 3](#t0015){ref-type="table"}). There were also significant improvements on anxiety (Cohen\'s *d* = 0.44; *p* \< 0.01) and depression (Cohen\'s *d* = 0.37; *p* \< 0.01).

3.5. Characteristics associated with sleep improvements {#s0080}
-------------------------------------------------------

We analysed the association between sleep improvement (ISI scores) and several patient and clinical characteristics using data of the 96 patients who completed the intervention and the questionnaires ([Table 4](#t0020){ref-type="table"}). Univariate linear regression analyses revealed three factors that were significantly associated with sleep improvement: younger age (*p* \< 0.01), higher baseline insomnia severity (*p* \< 0.01), and higher baseline daily fatigue (\< 0.05). However, daily fatigue was no longer associated with sleep improvements in the multivariate model. BRC patients who were younger (*p* \< 0.05) and had higher baseline insomnia levels (*p* \< 0.01) benefited the most from the intervention. These two variables explained 28% of the total variance in ISI scores reduction.Table 4Association between improvement in sleep complaints (ISI score) and other variables (linear regression analysis (a positive score indicates improvement).Table 4Univariate beta coefficient (95% CI)Multivariate beta coefficient (95% CI)Demographic characteristicsHigher age− 0.13 (− 0.23/− 0.4)^⁎⁎^− 0.09 (− 0.18/− 0.03)^⁎^Born in the Netherlands− 0.16 (− 2.7/2.4)--Higher education0.44 (− 1.4/2.3)--Living together1.47 (− 0.8/3.7)--Not in a paid job0.44 (− 1.9/2.7)--On sick leave1.55 (− 0.4/3.5)--  Type of treatmentTumorectomy− 0.8 (− 2.7/1.0)--Years between operation and admission to intervention0.01 (− 0.4/0.4)--Radiotherapy1.7 (− 0.2/3.6)--Chemotherapy1.49 (− 0.6/3.6)--Hormonal therapy0.07 (− 2.0/2.2)--with lymphe oedemia0.43 (− 1.4/2.3)  Sleep ProblemsMore severe sleep problems (ISI)0.65 (0.42/0.89)^⁎⁎^0.61 (0.37/0.84)^⁎⁎^More fatigue (FSS)0.09 (0.01/0.17)^⁎^Non significantWith sleep medication0.53 (− 1.29/2.35)--Sleep problems before breast cancer0.87 (− 0.96/2.70)--Sleep medication in history0.21 (− 1.79/2.21)--Other sleep treatment in history− 0.83 (− 4.11/2.46)--  Psychological symptoms and functioningMore severe HADS-anxiety0.19 (− 0.05/0.43)--More severe HADS-depression0.14 (− 0.13/0.40)--WSAS household0.07 (− 0.29/0.42)--WSAS work0.08 (− 0.21/0.38)--WSAS friendship− 0.17 (− 0.51/0.16)--WSAS social functioning− 0.14 (− 0.49/0.20)--[^3]

4. Discussion {#s0085}
=============

In this study we examined the feasibility and effects of a guided web-based CBT for insomnia in BRC patients. We demonstrated that the intervention is feasible because we had a high registration rate, a reasonable good adherence rate, and high treatment satisfaction scores. Those who completed the intervention and returned the post-test questionnaire (response rate 56%) improved on average 8 points on the Insomnia Severity Index which corresponds to a significant and large effect size (ITT *d* = 1.33). There were also significant improvements on all the secondary outcomes (fatigue, daytime functioning, anxiety and depression) although these effects were in the small to moderate range (between *d* = 0.24 and *d* = 0.44). Finally, we showed that younger women and women with more severe insomnia at baseline improved most.

The adherence rate of 59% is reasonably high, but lower than the adherence rate of 73% for the same internet intervention for insomnia in a non-cancer population ([@bb0180]). However, the treatment satisfaction scores were in the same range (7.5 vs 7.3). These findings suggest that completion of the insomnia intervention is more difficult for BRC patients. Possibly, we should adjust our treatment even more to the specific needs of BRC patients as was also suggested in the qualitative interviews.

The results of our study are in line with findings published previously in randomized controlled trials on self-administered treatment for insomnia in BRC patients ([@bb0150], [@bb0125]). First, our patients seemed to be comparable with respect to demographical characteristics as well as insomnia severity at baseline. Second our within effect size for insomnia severity (ITT *d* = 1.33) is in the same range as obtained in these two studies (*d* = 2.24 and *d* = 1.29, respectively).

Most of the women that were referred by routine care procedures were higher educated compared to women that were self-referred. Possibly, professionals assume that higher education is a necessary condition for participating in an internet intervention.

Our internet intervention was offered with coaching from a professional. This was highly appreciated by the patients. The women felt well understood and the coaching helped her to adhere to the treatment. In general, Internet interventions demonstrate higher effect sizes for guided interventions than for non-guided interventions ([@bb0165], [@bb0070]). Despite the patients\' appreciation of the support provided by the coaches, our effect size was not higher than in the other two studies which offered the interventions without any personal guidance. There might be several explanations for this. First, our study is not a RCT. It might be possible that our intervention would yield higher between group effect sizes in a RCT than the between group effect sizes in the other 2 studies. Secondly, our coaching might not have been properly conducted. This seems unlikely however since we used similar types of coaches and similar training procedures than other successful internet based studies we performed. Thirdly, it may be that the automated feedback in the other two interventions was as effective as the feedback of a professional. Further research into the additional effects of personal and automated guidance is warranted.

We tailored our I-Sleep intervention for breast cancer patients by adding psycho-education about breast cancer and insomnia, about hot flashes and insomnia, and about pain and insomnia. Furthermore, the case examples were based on real stories of BRC patients undergoing insomnia treatment. We assumed that all of this would lead to lower drop-out rates, which in turn would lead to greater effects. However, there is still little empirical data on the impact of tailoring of treatments to specific target groups and their effectiveness and most clinical studies conducted in cancer patients have not importantly adapted CBT-I to this specific population. Although our participants appreciated these adjustments, these adjustments may not be a necessary condition for improving sleep. On the other hand, some of the participants mentioned that they would have liked the intervention to be even more specific for BRC patients. This raises the question as to whether and to what extent we have to tailor web-based interventions for insomnia to specific subpopulations. Hypothetically the adjustments are mainly important in order to make the intervention more attractive for different subpopulations. In a systematic review by [@bb0155] on the factors that enhance user engagement of internet interventions, the importance of an individualized program is stated. Therefore, the personally tailored advice in the feedback of the coaches may be of more importance for adherence than the tailoring of the intervention itself.

Our results showed that younger patients with more severe insomnia benefited the most from the intervention. Nevertheless, the fact that 59% of the BRC patients who started the intervention also completed the intervention (and put in considerable effort in completing the exercises) indicates that the intervention was appreciated by a majority of BRC patients.

A limitation of this study was that the insomnia diagnoses were not assessed by clinical interviews. Hence, some patients may not have suffered from an insomnia disorder or they may have suffered from another sleep disorder (e.g. sleep apnea). According to the ISI, about 70% of our sample suffered from moderate to severe clinical insomnia. The lack of a control group is an important limitation as well as it is unclear whether the effects obtained are truly due to the treatment or to some non-specific factors (e.g., passage of time). However, the effect sizes obtained were of a similar magnitude as previous studies.

The conclusion of this study is that a guided web-based CBT intervention is a valuable addition in supportive cancer care, especially for younger patients and those with more severe insomnia.
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[^1]: Participant + both parents were born in the Netherlands.

[^2]: Cohen\'s *d* = the difference in pre- and post-test scores of participants by the pooled standard deviation.

[^3]: ^⁎^ \< 0.05; ^⁎⁎^ \< 0.01.
